Evidence map›Paper›PMID 27548113›Full record

ArticleJournal of the American Chemical Society2016

Total Synthesis of (-)-Lasonolide A.

Barry M Trost, Craig E Stivala, Daniel R Fandrick, Kami L Hull, Audris Huang, Caroline Poock, Rainer Kalkofen

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Barry M TrostDepartment of Chemistry, Stanford University , Stanford, California 94305-5080, United States.
Craig E StivalaDepartment of Chemistry, Stanford University , Stanford, California 94305-5080, United States.
Daniel R FandrickDepartment of Chemistry, Stanford University , Stanford, California 94305-5080, United States.
Kami L HullDepartment of Chemistry, Stanford University , Stanford, California 94305-5080, United States.
Audris HuangDepartment of Chemistry, Stanford University , Stanford, California 94305-5080, United States.
Caroline PoockDepartment of Chemistry, Stanford University , Stanford, California 94305-5080, United States.
Rainer KalkofenDepartment of Chemistry, Stanford University , Stanford, California 94305-5080, United States.

Funding

NOVEL SYNTHETIC APPROACHES TO ANTITUMOR COMPOUNDSR01GM033049 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI TROST, BARRY M · 1985 to 2016
$6.5M
Total Synthesis of Calyciphylline A - A Potent Cytotoxic AlkaloidF32GM101747 · NIGMS · STANFORD UNIVERSITY · PI STIVALA, CRAIG EVAN · 2012 to 2014
$150k
The Total Synthesis of (-)-Fijianolide DF32GM086093 · NIGMS · STANFORD UNIVERSITY · PI HULL, KAMI LEE · 2009 to 2011
$144k
A Novel Sterodivergent Approach to Amphidinolide NF32GM077840 · NIGMS · STANFORD UNIVERSITY · PI HUANG, AUDRIS · 2006 to 2009
$97k
NIGMS NIH HHS F32 GM077840NIGMS NIH HHS F32 GM086093NIGMS NIH HHS F32 GM101747NIGMS NIH HHS R01 GM033049
6 · The paper itself

Abstract

The lasonolides are novel polyketides that have displayed remarkable biological activity in vitro against a variety of cancer cell lines. Herein we describe our first-generation approach to the formal synthesis of lasonolide A. The key findings from these studies ultimately allowed us to go on and complete a total synthesis of lasonolide A. The convergent approach unites two highly complex fragments utilizing a Ru-catalyzed alkene-alkyne coupling. This type of coupling typically generates branched products; however, through a detailed investigation, we are now able to demonstrate that subtle structural changes to the substrates can alter the selectivity to favor the formation of the linear product. The synthesis of the fragments features a number of atom-economical transformations which are highlighted by the discovery of an engineered enzyme to perform a dynamic kinetic reduction of a β-ketoester to establish the absolute stereochemistry of the southern tetrahydropyran ring with high levels of enantioselectivity.

Indexed as

AlkenesAlkynesAntineoplastic AgentsCatalysisChemistry Techniques, SyntheticKineticsMacrolidesRutheniumStereoisomerismAlkenesAlkynesAntineoplastic Agentslasonolide AMacrolidesRuthenium

Identifiers

PMID27548113
PMCPMC5728428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.